\n\n\n\n\t\t\n\t\t\tPharmacyclics\n\t\t\thttp://www.pharmacyclics.com/\n\t\t
\n\t\t\n\t\t\tWatch Company\n\t\t\tGet Widget\n\t\t
\n\tPharmacyclics (NASDAQ:PCYC) is a pharmaceutical company developing novel agents to improve current therapeutic approaches to cancer, cardiovascular diseases, and inflammation. The company\u2019s products...More»
\n\t\t\tPharmacyclics (NASDAQ:PCYC) is a pharmaceutical company developing novel agents to improve current therapeutic approaches to cancer, cardiovascular diseases, and inflammation. The company\u2019s products are rationally designed, ring-shaped small molecules called texaphyrins. Texaphyrins selectively concentrate in diseased tissue, such as tumor cells and vulnerable plaque. They disrupt the bioenergetic processes of these cells, and when combined with other treatment modalities or various forms of energy, such as chemotherapy, radiation or light, apoptosis (programmed cell death) of the diseased tissue occurs. In this manner, texaphyrins can help to reduce or eliminate the diseased tissue. The physical and chemical characteristics of the texaphyrin molecules are determined by the type of metal inserted into the ring and the form of energy or other therapy used with it.«Less
\n\n\t\t\tOverview
\n\t\t\t\tLocation: \tSunnyvale, CA, United States\n
\n\t\t\t\tIndustry: Biopharmaceuticals
\n\t\t\t\tTags:\n\t\t\t\tmedical,\n\t\t\t\tTexaphyrins,\n\t\t\t\theart,\n\t\t\t\tinflamation,\n\t\t\t\tcancer,\n\t\t\t\ttumor,\n\t\t\t\tpharmacuticals,\n\t\t\t\ttherapeutic\n\t\t\t\t
\n\t\t\tMarket
\n\n\t\t\t\tRelated Companies:\n\t\t\t\t\tEBR Systems,\n\t\t\t\t\tAvantec Vascular,\n\t\t\t\t\tVarian Medical Systems,\n\t\t\t\t\tMonogram Biosciences,\n\t\t\t\t\tInterMune Pharmaceuticals,\n\t\t\t\t\tDynavax Technologies,\n\t\t\t\t\tKaloBios Pharmaceuticals,\n\t\t\t\t\tdiaDexus\n\t\t\t\t
\n\t\t\t